Previously, Ang-2 was thought to be primarily expressed in stromal endothelial cells and detectable in tumor cells in only a small percentage (12%) of tumor specimens collected from human ovarian cancer patients [12]. Here, ANGPT2 is linked to ovarian carcinoma.